Omnaris Spray
Product Images NDC 70515-701

10 FDA label images from Covis Pharma Us, Inc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Omnaris (NDC 70515-701). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Covis Pharma Us, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Image 01)

Structural Formula (Image 01)
Chemical structure of ciclesonide, the active ingredient in Omnaris nasal spray 50 mcg. The diagram shows the molecular arrangement, including hydroxyl and ketone groups characteristic of this corticosteroid compound.*
FDA Label Image

Figure 1 (Image 02)

Figure 1 (Image 02)
An illustrated diagram of a nasal spray bottle showing labeled parts including the dust cap, applicator tip, finger rests, pump, and glass bottle with plastic sleeve. The diagram provides a clear breakdown of the components of the nasal spray device.*
FDA Label Image

Figure 2 (Image 03)

Figure 2 (Image 03)
Illustration showing a hand holding a nasal spray bottle upright with a thumb positioned on the bottom and fingers wrapped around the nozzle, demonstrating the proper grip for administering the nasal spray.*
FDA Label Image

Figure 3 (Image 04)

Figure 3 (Image 04)
Instructional line drawing showing a hand preparing a nasal spray bottle by removing or handling the nasal applicator tip. The image visually represents how to hold the nasal spray device, likely for Omnaris (ciclesonide) 50 mcg nasal spray, for proper administration.*
FDA Label Image

Figure 4 (Image 05)

Figure 4 (Image 05)
An instructional illustration showing a person administering Omnaris nasal spray. The image depicts the individual inserting the spray nozzle into one nostril while pressing down on the bottle to release the spray, demonstrating the correct usage technique for this nasal spray medication.*
FDA Label Image

Figure 5 (Image 06)

Figure 5 (Image 06)
An instructional illustration showing hands wiping the nozzle tip of a nasal spray bottle with a tissue or cloth. The image demonstrates proper cleaning or maintenance of the nasal spray device, likely related to Omnaris (ciclesonide) nasal spray.*
FDA Label Image

Figure 6 (Image 07)

Figure 6 (Image 07)
An instructional illustration showing two hands assembling or preparing a nasal spray device, likely representing the Omnaris nasal spray with ciclesonide 50 micrograms. The right hand is holding the spray device's body, while the left hand is attaching or adjusting the spray nozzle or cap.*
FDA Label Image

Figure 7 (Image 08)

Figure 7 (Image 08)
An instructional diagram showing two steps for cleaning a nasal spray device. The top image illustrates rinsing the spray tip under running water, while the bottom image shows holding the spray bottle under running water for cleaning. Both illustrations depict a bathroom sink setting with additional bottles in the background.*
FDA Label Image

Figure 8 (Image 09)

Figure 8 (Image 09)
An instructional illustration showing two hands assembling a nasal spray by snapping the cap onto the spray bottle. The image indicates the correct way to attach the cap with an arrow and the word 'SNAP!'.*
FDA Label Image

Principal Display Panel (50 mcg Carton Label)

Principal Display Panel (50 mcg Carton Label)
The packaging label for Omnaris (ciclesonide) Nasal Spray, 50 mcg, by Covis Pharma US, Inc. It details 120 metered actuations in a 12.5 g container. The label includes usage instructions, warnings about fragility, and pharmacist and patient advisories. It also lists storage conditions and cautions against spraying in eyes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.